Plasma p-tau217 had higher accuracy for identifying Aβ PET and biological AD (Aβ and tau PET positivity) than plasma p-tau181 and plasma p-tau231, with not significantly different results from CSF variations of these markers [107]. This evidence concerns the gene MAPT and Alzheimer disease.